key: cord-0887928-1ote7j6z
authors: Fronza, Matteo; Thavendiranathan, Paaladinesh; Karur, Gauri Rani; Abdel-Qadir, Husam; Udell, Jacob A.; Wald, Rachel M.; Hanneman, Kate
title: Cardiac MRI and Clinical Follow-up in COVID-19 Vaccine–associated Myocarditis
date: 2022-05-03
journal: Radiology
DOI: 10.1148/radiol.220802
sha: f4ffdbc5873c6458ea040c06ba663d0bd6ddde64
doc_id: 887928
cord_uid: 1ote7j6z

nan

Toronto, Ontario M5G 2N2 Email: kate.hanneman@uhn.ca Twitter: @katehanneman "In Press" papers have undergone full peer review and have been accepted for publication in Radiology. This article will undergo copyediting, layout, and proof review before it is published in its final version. Please note that during production of the final copyedited article, errors may be discovered which could affect the content. 

We previously reported cardiac MRI findings in a cohort of patients with COVID-19 vaccine associated myocarditis (1) . The majority of patients had mild imaging abnormalities at the time of acute symptoms.

However, little is known about later evolution of the cardiac MRI abnormalities.

The institutional ethics committee approved this retrospective analysis and waived the requirement for written informed consent. Cardiac MRIs were performed at 1.5T or 3T (Siemens, Germany) and were analyzed blinded to all clinical information (Circle cmr42; Canada). Global longitudinal, circumferential and radial strain was analyzed using feature-tracking analysis. Late gadolinium enhancement (LGE) was quantified using a signal-intensity threshold of 4SD. Maximum native T1 and T2 were converted to zscores using scanner-specific local reference values (1).

Thirteen patients had follow-up cardiac MRI (mean age, 33±14 years, 77% men) (Table) . All patients had chest pain at presentation that followed mRNA-1273 in 9 (69%) and BNT162b2 in 4 (31%). Six patients (46%) required hospitalization. Six were treated with colchicine (46%), three with aspirin (23%), and three with ibuprofen (23%). (Table) . LGE had resolved in 3/13 (23%), decreased in 8/13 (62%), and remained negative in 2/13 (15%). In patients with residual LGE, the extent at follow-up was minimal (range, 1-2 grams). Left ventricular ejection fraction increased and was normal in all at follow-up (56±4% vs. 60±3%, p=.003). I n p r e s s

Myocardial Injury Pattern at MRI in COVID-19

Vaccine-associated Myocarditis

Cardiac MRI Assessment of Nonischemic Myocardial Inflammation: State of the Art Review and Update on Myocarditis Associated with COVID-19 Vaccination